New members required for the BOPA Digital Subcommittee

The BOPA digital subcommittee are looking for new members. The primary purpose of the BOPA digital subcommittee is to promote excellence in the pharmaceutical care of patients by supporting membership through digital support and increased communication streams. The group has 4 pillars – membership, website, social media and education and technology. More details on the role of the group can be found here

We are looking for members who have a passion for getting information to people in different ways.

If you are interested or would like to know more, please contact [email protected] for further information.

Latest News

By BOPA E&T Subcommittee on 12th February 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine-month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. First session: Wednesday 26th February 12:30pm Join in this relaxed forum…

Read article
By BOPA research committee on 10th February 2025

SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma

Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients! The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the…

Read article
By BOPA on 3rd February 2025

UKPPL Board and BOPA Webinar (Wednesday12th Feb 2025): Collaborative Pharmacy Professional Leadership

Wednesday 12th February 2025 16:00 GMT   ‘Enabling us to be the best that pharmacy can be’ webinars will be held across the UK from 3rd to 25th February 2025,…

Read article
By BOPA Committee on 31st January 2025

Publication update: National SACT regimen specific consent forms for bladder cancer

Dear All,   National SACT regimen specific bladder cancer forms have been reviewed and updated. All forms can be found here: www.cruk.org/sact_consent. Please share this update with your clinical teams…

Read article